Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders (eBook)

eBook Download: PDF
2016 | 1st ed. 2016
IX, 117 Seiten
Springer International Publishing (Verlag)
978-3-319-27040-1 (ISBN)

Lese- und Medienproben

Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders -
Systemvoraussetzungen
53,49 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen

Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed.

Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice. 



Prof. Janusz K. Rybakowski has been the Head of Department of Adult Psychiatry, Poznan University of Medical Sciences, Poland, since 1994. He has authored over 500 scientific articles and book chapters on clinical psychiatry, neurobiology and psychopharmacology and his present Hirsch Index is 40. He is the author of the book 'The Faces of Manic-Depressive Illness' (2009) and a member of many scientific societies including ECNP, CINP, Society of Biological Psychiatry, International Society of Psychiatric Genetics, International Society of Affective Disorders and International Society of Bipolar Disorders. He serves on editorial boards of numerous international journals and is the Field Editor of the World Journal of Biological Psychiatry. From 1998-2001 he was the President of the Polish Psychiatric Association. In 2012, he received the Lifetime Achievement Award of the European Bipolar Forum and in 2015, the Lifetime Achievement Award in Biological Psychiatry.

Prof. Janusz K. Rybakowski has been the Head of Department of Adult Psychiatry, Poznan University of Medical Sciences, Poland, since 1994. He has authored over 500 scientific articles and book chapters on clinical psychiatry, neurobiology and psychopharmacology and his present Hirsch Index is 40. He is the author of the book “The Faces of Manic-Depressive Illness” (2009) and a member of many scientific societies including ECNP, CINP, Society of Biological Psychiatry, International Society of Psychiatric Genetics, International Society of Affective Disorders and International Society of Bipolar Disorders. He serves on editorial boards of numerous international journals and is the Field Editor of the World Journal of Biological Psychiatry. From 1998-2001 he was the President of the Polish Psychiatric Association. In 2012, he received the Lifetime Achievement Award of the European Bipolar Forum and in 2015, the Lifetime Achievement Award in Biological Psychiatry.

1. Pharmacogenetics of the Efficacy of Antipsychotic Drugs in Schizophrenia.- 2. Pharmacogenetics of Serious Antipsychotic Side-Effects.- 3. Pharmacogenetics of the Efficacy and Side Effects of Antidepressant Drugs.- 4. Genomic Studies of Treatment Resistance in Major Depressive Disorders.- 5. Complementation of Pharmacogenetics with Biomarkers and Neuroimaging in Major Depression.- 6. Pharmacogenetics of Mood Stabilizers.- 7. Practical Application of Pharmacogenetics of Antipsychotic, Antidepressant and Mood-Stabilizing Drugs.

Erscheint lt. Verlag 4.2.2016
Zusatzinfo IX, 117 p.
Verlagsort Cham
Sprache englisch
Themenwelt Medizin / Pharmazie Pharmazie
Schlagworte antidepressants • antipsychotic drugs • Biomarkers • Mood-Stabilizing Drugs • neuroimaging • Pharmacogenetics • Psychopharmacology • Schizophrenia • Side effects • Treatment-resistant depression
ISBN-10 3-319-27040-0 / 3319270400
ISBN-13 978-3-319-27040-1 / 9783319270401
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 1,7 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Grundlagen und Fallbeispiele für das Medikationsmanagement

von Ina Richling; Ina Richling

eBook Download (2023)
Deutscher Apotheker Verlag
48,00
Schritt-für-Schritt-Anleitungen für die Apotheke

von Annina Bergner

eBook Download (2021)
Deutscher Apotheker Verlag
28,00